Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

N-Oxides as Hypoxia Selective Cytotoxins

Author(s): Hugo Cerecetto and Mercedes Gonzalez

Volume 1, Issue 3, 2001

Page: [219 - 231] Pages: 13

DOI: 10.2174/1389557013406891

Price: $65

Abstract

N-Oxide-containing compounds have been developed as prodrugs that are selectively bioactivated in the hypoxic cells in tumors. This selectivity is based on the net reduction of the N-oxide moiety in the absence of oxygen, in a one or two-electron process, by reductive enzymes. A wide range of N-oxides have been studied and some of them are currently in clinical use. This review covers the principal families of compounds under study and in clinical trials.

Keywords: N-Oxides, Hypoxia, Cytotoxins, Tumor Hypoxia, Bioreductive Agents, Imidazopyridopyrazine N-Oxide and Imidazoquin-oxaline N-Oxide, Quinoxaline N,N-Dioxide, Aminoalkylaminoanthraquinone N-Oxide, Aminoalkylaminoacridine N-Oxide

Next »

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy